【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2013 14
2.2.1 AstraZeneca to Acquire Remaining 50% Interest in Diabetes Joint Venture from Bristol-Myers Squibb for US$4.3 Billion 14
2.2.2 Johnson & Johnson Prices Public Offering of Notes for US$3.5 Billion 15
2.2.3 OncoMed Pharma Enters into Co-Development Agreement with Celgene 16
2.2.4 Thermo Fisher Scientific Completes Public Offering of Notes for US$3.2 Billion 17
2.2.5 Genmab Expands Licensing Agreement With Janssen Biotech 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2013 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2013 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2013 21
3.1.1 Top M&A Deals in December 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2013 – December 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2013 24
3.2.1 Top Equity Offering Deals in December 2013 25
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2013 – December 2013 26
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2013 27
3.3.1 Top PE/VC Deals in December 2013 28
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2013 29
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2013 30
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2013–December 2013 32
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2013–December 2013 33
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2013 34
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2013 34
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2013 – December 2013 36
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2013 37
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2013 38
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2013 – December 2013 39
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2013 – December 2013 41
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2013 – December 2013 42
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2013 – December 2013 44
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2013 46
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2013 46
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2013 48
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2013 49
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2013 50
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2013 50
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2013 – December 2013 51
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2013 – December 2013 53
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2013 – December 2013 55
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2013 – December 2013 57
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 59
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2013 59
6.1.1 Oncology – Deals of the Month 61
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2013 63
6.2.1 Central Nervous System – Deals of the Month 65
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2013 67
6.3.1 Infectious Diseases – Deals of the Month 69
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, December 2013 70
6.4.1 Metabolic Disorders – Deal of the Month 72
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2013 73
6.5.1 Immunology – Dealsof the Month 75
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2013 76
6.6.1 Cardiovascular – Deal of the Month 77
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, December 2013 78
6.7.1 Respiratory – Deals of the Month 79
7 Deal Summary by Geography 80
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2013 80
7.1.1 North America – Deals of the Month 81
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2013 83
7.2.1 Europe – Deals of the Month 85
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2013 86
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2013 89
7.4.1 Rest of the World – Deals of the Month 90
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 91
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2013 – December 2013 91
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2013 – December 2013 93
9 Further Information 95
9.1 Methodology 95
9.2 About GlobalData 96
9.3 Disclosure information 97
9.4 Disclaimer 97
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：December 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for December 2013 in Pharmaceuticals
■ 発行日：2014年1月27日
■ 調査会社：GlobalData
■ 商品コード：GDATA403163519
■ 調査対象地域：グローバル
- スマート油田の世界市場2016-2020About Smart Oilfields Smart oilfield involves the application of advanced software, hardware, and data analysis techniques to increase the E&P efficiency of oil and gas. In an era of ever-growing energy demand and depletion of “easy oil,” smart oilfields facilitate in maximizing oilfield recovery by reducing downtime. These oilfields increase the ROI and profitability through effective integration …
- 世界における特殊合成繊維及びガラス繊維市場動向及び予測（～2018）The specialty synthetic fibers and glass fiber market had a consumption of 4,652,100.2 MT in 2012, with the highest share held by Glass fiber. The global market is projected to grow at a CAGR of 5.2% from 2013 to 2018. The highest revenue is forecasted to be for glass fiber, owing to the low pricing as compared to other specialty synthetic fibers, growing application markets, availability of raw m …
- リン酸肥料のグローバル市場（～2019）The industry report Global Phosphatic Fertilizer Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for phosphatic fertilizers in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, market …
- 2014 Leading Flow Cytometry Market Players: Strategic Assessments of Major Suppliers and Emerging Market EntrantsThis new report from Venture Planning Group presents strategic analyses of major current and emerging suppliers of flow cytometry analyzers and consumables in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 25 pages
- 細胞治療の世界市場Pharmaceutical companies are actively looking for different modalities which could help in generating more revenues by competing with existing products. Traditional therapeutic have modest safety and efficacy levels and newer options are required to overcome their shortcomings. In this quest, they have focused upon cell therapy which holds both pharmacological and commercialization potential. Thei …
- 半導体用プロセス制御装置の世界市場：半導体検査装置、半導体計測装置、プロセス制御ソフトウェアAbout Semiconductor Market The global semiconductor market is migrating toward more complex and miniaturized devices. With the industry migrating toward smaller node sizes of 10 nm and below, semiconductor device manufacturers seek higher inspection sensitivity, metrology sensitivity, and updated software to control the manufacturing process. Technological advances in semiconductor fabrication hav …
- 水路測量装備のグローバル市場動向（2014 – 2020）The global hydrographic and equipment market value is expected to reach $2,934.18 million by 2020. The sector demands high-resolution sound and acoustic products and precise positioning systems in the future. The report discusses the hydrographic equipment market in the period from 2014 to 2020. The market has been segmented into four major application areas utilizing the equipment, namely hydrogr …
- Kallisto Energy Corp.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Kallisto Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Kallisto Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 骨内注入用機器の世界市場2017-2021About Intraosseous Infusion Devices Market The global intraosseous infusion devices market is growing steadily, primarily due to rise in emergency medical cases, which manage critical or life threatening conditions. The market is driven by the rise in the incidence of chronic disorders such as cardiovascular diseases, traumatic injuries, severe burns, and obesity. Intraosseous devices have a high …
- LTE-Advanced (LTE-A)無線通信技術の世界市場In the last 6 years, the global mobile telecoms industry has been shaped by the introduction of 4G LTE technology. This mobile technology has not only changed the way we communicate, but it has also affected our lives in many different ways from the type of media we watch to the amount of devices we buy. Due to this, the number of deployments and subscriptions of 4G have been booming in the last t …
- ビリヤード及びスヌーカー用品の世界市場予測・分析2020-2024Global Billiards and Snooker Equipment Market: About this market Technavio’s billiards and snooker equipment market analysis considers sales from billiards and snooker tables, billiards and snooker cues and balls, and other equipment products. Our study also finds the sales of billiards and snooker equipment in APAC, Europe, MEA, North America, and South America. In 2019, the billiards and snooker …
- 在宅医療用酸素濃縮器の世界市場2018-2022About Homecare Oxygen Concentrators An oxygen concentrator is a medical device used to deliver oxygen to patients who have a medical condition that causes or results in low levels of oxygen in the blood. Technavio’s analysts forecast the Global Homecare Oxygen Concentrators Market to grow at a CAGR of 8% during the period 2018-2022. Covered in this report The report covers the present scenario and …
- グリーンマイニング（環境配慮型鉱業）の世界市場予測（～2024年）“The increasing use of sustainable mining technologies by the mining companies to drive the market.” The green mining market size is estimated at USD 9.0 billion in 2019 and is projected to reach USD 12.9 billion by 2024, at a CAGR of 7.5%. The green mining market is driven by mining companies these days, which are working on several sustainable practices that are an essential part of their proces …
- インベストメント鋳造のグローバル市場動向（2014-2018）About Investment Casting Investment casting is an industrial process in which high technology waxes are used to form patterns that allow the production of components with accuracy, repeatability, versatility, and integrity in a variety of metals and high-performance alloys. TechNavio's analysts forecast the Global Investment Casting market will grow at a CAGR of 5.68 percent over the period 2014-2 …
- 市場統合シナリオ：Orthopedics Market Consolidation: Who will not survive?This report provides a worldwide strategic overview of the orthopedics market, including: In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc. The analysis of major market segments, …
